NanoZymeX Pre-Seed

Biotech startup NanoZymeX has secured €160,000 (approximately $0.2 million) in pre-seed funding from Venture Kick. The company is developing a novel lipid nanoparticle platform to enhance enzyme replacement therapies for rare genetic disorders by improving targeted delivery and reducing immune responses. This funding will support further preclinical development and preparation for future financing rounds.